By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Radius 

201 Broadway
6th Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-551-4700 Fax: 617-551-4701


SEARCH JOBS


Industry
Pharmaceutical






Company News
Radius (RDUS) Announces Oral Presentation Of The ACTIVE Phase 3 Clinical Trial Of Abaloparatide-SC For Postmenopausal Women With Osteoporosis At The International Society Of Endocrinology And The Endocrine Society (ICE/ENDO 2015) 1/29/2015 7:41:46 AM
Radius (RDUS) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 1/28/2015 10:54:58 AM
Radius (RDUS) Announces Pricing Of Public Offering 1/23/2015 7:20:43 AM
Radius (RDUS) Announces Proposed Public Offering 1/21/2015 7:32:59 AM
Radius (RDUS) Announces Follow-Up On The Positive Phase 3 Top-Line Results For Its Investigational Drug Abaloparatide-SC In Postmenopausal Women With Severe Osteoporosis 1/12/2015 6:49:55 AM
Radius (RDUS) Announces Positive Phase 3 Top-Line Results For Its Investigational Drug Abaloparatide-SC In Postmenopausal Women With Severe Osteoporosis 12/22/2014 7:14:13 AM
FDA Accepts IND Application For Radius (RDUS)'s Investigational Drug RAD1901 Being Developed For Potential Use In Metastatic Breast Cancer 12/15/2014 8:18:06 AM
Radius (RDUS) Presents RAD1901 Data At 2014 San Antonio Breast Cancer Symposium 12/11/2014 7:42:44 AM
Radius (RDUS) Reports Third Quarter 2014 Financial And Operating Results 11/11/2014 10:24:33 AM
Radius (RDUS) Appoints Industry Veteran Dr. Willard Dere To Board Of Directors 11/3/2014 10:18:02 AM
1234567
//-->